Cases of neuromyelitis optica spectrum disorder from the East Africa region, highlighting challenges in diagnostics and healthcare access

Wingerchuk, 2015, International consensus diagnostic criteria for neuromyelitis optica spectrum disorders, Neurology., 85, 177, 10.1212/WNL.0000000000001729 Hamid, 2017, What proportion of AQP4-IgG-negative NMO spectrum disorder patients are MOG-IgG positive? A cross sectional study of 132 patients, J. Neurol., 264, 2088, 10.1007/s00415-017-8596-7 Jurynczyk, 2017, Clinical presentation and prognosis in MOG-antibody disease: a UK study, Brain., 140, 3128, 10.1093/brain/awx276 Jurynczyk, 2019, Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease: practical considerations, Pract. Neurol., 19, 187, 10.1136/practneurol-2017-001787 Palace, 2012, A practical guide to the treatment of neuromyelitis optica, Pract. Neurol., 12, 209, 10.1136/practneurol-2012-000237 Holroyd, 2019, Neuromyelitis optica testing and treatment: availability and affordability in 60 countries, Mult. Scler. Relat. Disord., 33, 44, 10.1016/j.msard.2019.05.013 Ogbole, 2018, Survey of magnetic resonance imaging availability in West Africa, Pan. Afr. Med. J., 30, 240, 10.11604/pamj.2018.30.240.14000 Alvarenga, 2017, Epidemiology of neuromyelitis optica in Latin America, Mult. Scler. J. Exp. Transl. Clin., 3 Marrie, 2013, The incidence and prevalence of neuromyelitis optica: a systematic review, Int. J. MS Care., 15, 113, 10.7224/1537-2073.2012-048 Hor, 2018, Prevalence of neuromyelitis optica spectrum disorder in the multi-ethnic Penang Island, Malaysia, and a review of worldwide prevalence, Mult. Scler. Relat. Disord., 19, 20, 10.1016/j.msard.2017.10.015 Bukhari, 2017, Incidence and prevalence of NMOSD in Australia and New Zealand, J. Neurol. Neurosurg. Psychiatry, 88, 632, 10.1136/jnnp-2016-314839 2019 Bennis, 2019, Clinical course of neuromyelitis optica spectrum disorder in a moroccan cohort, Mult. Scler. Relat. Disord., 30, 141, 10.1016/j.msard.2019.02.012 Salama, 2018, Clinical and radiological characteristics of neuromyelitis optica spectrum disorder in the north Egyptian Nile Delta, J. Neuroimmunol., 324, 22, 10.1016/j.jneuroim.2018.08.014 Kishk, 2019, Demographics and clinical characteristics of Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorder in Egypt: first retrospective longitudinal study in a tertiary referral centre, ECTRIMS Online Libr., 278339 Gaye, 2019, Neuromyelitis optica spectrum disorders (NMO-SD) in a sub-Saharan Africa country: a preliminary study of sixteen Senegalese cases, Mult. Scler. Relat. Disord., 27, 179, 10.1016/j.msard.2018.10.108 Daoudi, 2016, Neuromyelitis optica spectrum disorders in Algeria: a preliminary study in the region of Tizi Ouzou, Mult. Scler. Relat. Disord., 6, 37, 10.1016/j.msard.2015.12.005 Assadeck, 2019, Inflammatory demyelinating diseases of the central nervous system in Niger, Rev. Neurol. (Paris), 175, 261, 10.1016/j.neurol.2018.05.003 Kadjo, 2019, Devic’s optica neuromyelitis (NMOSD) in ivory coast: a second confirmed case report, Afr. J. Neurol. Sci., 38 Bhigjee, 2017, The neuromyelitis optica presentation and the aquaporin-4 antibody in HIV-seropositive and seronegative patients in KwaZulu-Natal, South Africa, South Afr. J. HIV Med., 18, 684, 10.4102/sajhivmed.v18i1.684 Kaddumukasa, 2013, Neuromyelitis optica in a Ugandan woman: a case report, J. Med. Case Rep., 7, 177, 10.1186/1752-1947-7-177 Flanagan, 2016, Epidemiology of aquaporin-4 autoimmunity and neuromyelitis optica spectrum, Ann. Neurol., 79, 775, 10.1002/ana.24617 Storoni, 2012, Optic neuritis in an ethnically diverse population: higher risk of atypical cases in patients of African or African-Caribbean heritage, J. Neurol. Sci., 312, 21, 10.1016/j.jns.2011.08.030 Mealy, 2012, Epidemiology of neuromyelitis optica in the United States: a multicenter analysis, Arch. Neurol., 69, 1176, 10.1001/archneurol.2012.314 Fragoso, 2019, Clinical characteristics of 153 Brazilian patients with neuromyelitis optica spectrum disorder (NMOSD), Mult. Scler. Relat. Disord., 27, 392, 10.1016/j.msard.2018.11.031 Sokhi, 2017, Diagnostic audit of the largest cohort of multiple sclerosis cases in Kenya referred to a tertiary hospital in Nairobi, J. Neurol. Sci., 381, 1061, 10.1016/j.jns.2017.08.2998 Weerasinghe, 2016, Mimics and chameleons of optic neuritis, Pract. Neurol., 16, 96, 10.1136/practneurol-2015-001254 Hamid, 2017, The impact of 2015 neuromyelitis optica spectrum disorders criteria on diagnostic rates, Mult. Scler., 23, 228, 10.1177/1352458516663853 Waters, 2014, Evaluation of aquaporin-4 antibody assays, Clin. Exp. Neuroimmunol., 5, 290, 10.1111/cen3.12107 Jarius, 2012, Contrasting disease patterns in seropositive and seronegative neuromyelitis optica: a multicentre study of 175 patients, J. Neuroinflammation, 9, 14, 10.1186/1742-2094-9-14 WHO, 2017 Mealy, 2019, Long-term disability in neuromyelitis optica spectrum disorder with a history of myelitis is associated with age at onset, delay in diagnosis/preventive treatment, MRI lesion length and presence of symptomatic brain lesions, Mult. Scler. Relat. Disord., 28, 64, 10.1016/j.msard.2018.12.011 Pandit, 2013, Optimizing the management of neuromyelitis optica and spectrum disorders in resource poor settings: experience from the Mangalore demyelinating disease registry, Ann. Indian Acad. Neurol., 16, 572, 10.4103/0972-2327.120474 Kim, 2012, Does interferon beta treatment exacerbate neuromyelitis optica spectrum disorder?, Mult. Scler., 18, 1480, 10.1177/1352458512439439 Zhong, 2018, Infections in neuromyelitis optica spectrum disorder, J. Clin. Neurosci., 47, 14, 10.1016/j.jocn.2017.10.005 Brey, 2014, Relapsing neuromyelitis optica temporally related to recurrent pulmonary tuberculosis, Int. J. Tuberc. Lung Dis., 18, 632, 10.5588/ijtld.13.0911 Marin Collazo, 2018, Neuromyelitis Optica and herpes simplex virus 2: a viral trigger for Aquaporin-4 autoimmunity?, Neurologist., 23, 92, 10.1097/NRL.0000000000000172 Wilcox, 2008, Neuromyelitis optica (Devic’s disease) in a patient with syphilis, Mult. Scler., 14, 268, 10.1177/1352458507082355 Sokhi, 2015, Four-stage audit demonstrating increased uptake of HIV testing in acute neurology admissions using staged practical interventions, PLoS One, 10, 10.1371/journal.pone.0134574 Kleiter, 2016, Neuromyelitis optica: evaluation of 871 attacks and 1,153 treatment courses, Ann. Neurol., 79, 206, 10.1002/ana.24554